文献速递生殖医学母胎医学

已知嵌合体胚胎移植后出生嵌合体婴儿:一例病例报告

The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report.
PubMed 文献 · Hum Reprod · 2020-01-01

一例39岁卵巢储备减退女性仅一枚囊胚可活检,移植2号染色体单体嵌合率35%的胚胎后妊娠,羊膜腔穿刺显示嵌合型核型mos46,XX(98)/47,XX,+2(2),足月分娩健康女婴,外周血染色体分析荧光原位杂交验证显示2%嵌合型2号染色体单体。这是首例已知嵌合体胚胎移植后真性胎儿嵌合体并活产的报道。

要点

  • 嵌合体胚胎移植可作为无整倍体胚胎时的选择,尤其卵巢储备减退或高龄女性。
  • 本例移植35%嵌合型2号染色体单体胚胎后,羊膜腔穿刺发现低比例嵌合型三体2。
  • 提示嵌合体胚胎移植后需密切产前监测,建议>14周行早期羊膜腔穿刺诊断。

核心结论

  • 已知嵌合体胚胎移植后可发生真性胎儿嵌合体并活产健康婴儿,需密切产前监测与诊断。

研究设计与样本

  • 病例报告:一例39岁卵巢储备减退女性,仅一枚囊胚可活检,移植2号染色体单体嵌合率35%的胚胎。

主要发现

  • 移植后妊娠,羊膜腔穿刺显示mos46,XX(98)/47,XX,+2(2)嵌合型核型。
  • 详细超声未见病理发现,胎儿生长正常,无宫内生长迟缓证据。
  • 孕37周分娩健康女婴,外周血染色体分析经荧光原位杂交验证显示2%嵌合型2号染色体单体[mos45,XX,-2(2)/46,XX(98)]。

关键数值与推荐

  • 胚胎2号染色体单体嵌合率35%。
  • 羊膜腔穿刺核型mos46,XX(98)/47,XX,+2(2)。
  • 外周血荧光原位杂交验证2%嵌合型2号染色体单体[mos45,XX,-2(2)/46,XX(98)]。

临床怎么用

  • 嵌合体胚胎移植可作为无整倍体胚胎时的选择,尤其卵巢储备减退或高龄女性。
  • 移植已知嵌合体胚胎后应密切产前监测,建议>14周行早期羊膜腔穿刺诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mosaic embryos have the potential to implant and develop into healthy babies. The transfer of mosaic embryos is now considered to be a possible option for women undergoing ART with preimplantation genetic testing for aneuploidies and in the absence of euploid embryos, particularly those with diminished ovarian reserve and/or advanced maternal age. It can aid in avoiding the discard of potentially viable embryos, which might otherwise result in healthy babies. In over 500 studies on mosaicism, there have been no reports of mosaicism in babies born following the transfer of mosaic embryos. Here, we present a case report of a 39-year-old woman with diminished ovarian reserve with only one blastocyst available for trophectoderm biopsy. The transfer of the embryo, which showed 35% mosaicism of monosomy 2, resulted in pregnancy. Amniocentesis revealed a mosaic trisomic mos46,XX(98)/47,XX,+2(2) karyotype. There were no pathological findings in detailed ultrasonography, and the fetus showed a normal fetal growth with no evidence of intrauterine growth retardation. A healthy female baby was born at Week 37. The peripheral blood chromosome analysis validated with fluorescence in situ hybridization showed 2% mosaic monosomy 2 [mos45,XX,-2(2)/46,XX(98)]. This is the first reported case of true fetal mosaicism resulting in a live birth following the transfer of a known mosaic embryo. Worldwide, prenatal diagnosis has shown the depletion of mosaicism in embryos transferred after they have been reported as mosaics. Our case demonstrates the need for close prenatal monitoring and diagnosis by early amniocentesis, preferably at >14 weeks gestation.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kahraman S, Cetinkaya M, Yuksel B, et al. The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report. Hum Reprod. 2020. PMID: 32155260. doi:10.1093/humrep/dez309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。